Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The urea cycle is a critical metabolic pathway in the liver responsible for converting toxic ammonia, a byproduct of amino acid metabolism, into urea for safe excretion in urine. Arginine is both an intermediate and a regulator within this cycle. Supplementation with arginine can enhance urea cycle function, particularly under conditions where endogenous arginine synthesis or availability is limited. Supplemental arginine increases substrate availability, promoting more efficient conversion of ammonia into urea, reducing hyperammonemia risk. Enhanced flux through the urea cycle may also support anabolic processes. Oral or intravenous administration of L-arginine is used clinically as adjunct therapy in certain inherited disorders of the urea cycle to improve nitrogen disposal capacity.
Arginine supplementation increases substrate availability for the urea cycle, enhancing the conversion of ammonia to urea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urea Cycle (enhancement via arginine supplementation) (None).